Cordyceps Sunshine Biotech Holdings Co Ltd. Stock Analysis RAJAF
Cordyceps Sunshine Biotech Holdings Co., Ltd. specializes in the cultivating and sale of cordyceps. The company is headquartered in Taipei City, Taipei and currently employs 15 full-time employees. The company went IPO on 2023-10-09. The primary product is Cordyceps, Ophiocordyceps Sinensis, a valuable Chinese medicinal material with a long history of application in China. The firm produces two kinds of Cordyceps, including dry Cordyceps and fresh Cordyceps. Dry cordyceps has a long shelf life and is convenient to store and carry, fresh Cordyceps has a short shelf life and is inconvenient to store and carry. The products are cultivated in its breeding center. The firm commissioned third party quality testing institution to perform quality testing for products to ensure quality control.
Read More Cordyceps Sunshine Biotech Holdings Co Ltd (RAJAF) Chart
Key Statistics of Cordyceps Sunshine Biotech Holdings Co Ltd (RAJAF)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$5.20Volume
261.00P/E Ratio (TTM)
-52 Week Range
Market Cap
577.82MAvg. Volume
261.00Dividend Yield
-Financial Metrics & Statements of Cordyceps Sunshine Biotech Holdings Co Ltd (RAJAF)
FAQ's for Cordyceps Sunshine Biotech Holdings Co Ltd (RAJAF)
- According to Musaffa’s Shariah screening methodology, Cordyceps Sunshine Biotech Holdings Co Ltd (RAJAF) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.